PTCH2 and neoplasm: From the increased baseline pathway activity and associated tumor growth following Ptch2 targeting in vivo, we conclude that Ptch2 exerts ligand-independent pathway inhibitory functions that make it a tumor suppressor, but one that is also required and essential for cancer cell viability.